Product Name: CGGBP1 Antibody
Species Reactivity: Human
Tested Applications: WB
Applications: For WB starting dilution is: 1:1000
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 19 kDa
Immunogen: This CGGBP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 126-152 amino acids from the C-terminal region of human CGGBP1.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 76095-16-4
Product: Enalapril (maleate)
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.5 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: CGG triplet repeat-binding protein 1, CGG-binding protein 1, 20 kDa CGG-binding protein, p20-CGGBP DNA-binding protein, CGGBP1, CGGBP
Accession NO.: Q9UFW8
Protein Ino: 116243045
Official Symbol: CGGBP1
Geneid: 8545
Background: CGGBP1 influences expression of the FMR1 gene (MIM309550), which is associated with the fragile X mental retardationsyndrome (MIM 300624), by specifically interacting with the 5-prime(CGG)n-3-prime repeat in its 5-prime UTR.
PubMed ID:http://aac.asm.org/content/35/12/2526.abstract
